Jakubek Lab
Publications (dedicated to NPU=N or Biocev=B, international collaboration=I, collaboration with hospital=H, from group in Inst.131/from Detached group)
Vozniuk O, Kejík Z, Veselá K, Skaličková M, Novotný P, Hromádka R, Hajduch J, Martásek P, Jakubek M. A Fast HPLC/UV Method for Determination of Ketoprofen in Cellular Media. ChemistryOpen. 2024 Mar;13(3):e202300147. doi: 10.1002/open.202300147. (IF 2.3, Q3) [Link]
Mackova V, Raudenska M, Polanska HH, Jakubek M, Masarik M. Navigating the redox landscape: reactive oxygen species in regulation of cell cycle. Redox Rep. 2024 Dec;29(1):2371173. doi: 10.1080/13510002.2024.2371173. (IF 5.2, Q1) [PubMed]
Kejík Z, Hajduch J, Abramenko N, Vellieux F, Veselá K, Fialová JL, Petrláková K, Kučnirová K, Kaplánek R, Tatar A, Skaličková M, Masařík M, Babula P, Dytrych P, Hoskovec D, Martásek P, Jakubek M. Cyanine dyes in the mitochondria-targeting photodynamic and photothermal therapy. Commun Chem. 2024 Aug 13;7(1):180. doi: 10.1038/s42004-024-01256-6. (IF 5.9, Q1) [PubMed]
Abramenko N, Vellieux F, Veselá K, Kejík Z, Hajduch J, Masařík M, Babula P, Hoskovec D, Pacák K, Martásek P, Smetana K Jr, Jakubek M. Investigation of the potential effects of estrogen receptor modulators on immune checkpoint molecules. Sci Rep. 2024 Feb 6;14(1):3043. doi: 10.1038/s41598-024-51804-2. (IF 4.6, Q2) [Link]]
Król-Kulikowska M, Abramenko N, Jakubek M, Banasik M, Kepinska M. The Role of Angiotensin-Converting Enzyme (ACE) Polymorphisms in the Risk of Development and Treatment of Diabetic Nephropathy. J Clin Med. 2024 Feb 8;13(4):995. doi: 10.3390/jcm13040995. (IF 3.9, Q2) [Link]
Kotaška K, Werle J, Hosnedlova B, Kizek R, Průša R. Use of Fourier transform infrared (FTIR) spectroscopy to detect rarely occurring cyanoacrylate and pyrophosphate urine stones. Applied Spectroscopy Reviews. 2023, 58 (10). doi:10.1080/05704928.2022.2138423 (IF 6.1, Q1) [Link]
Veselá K, Mělková Z, Abramenko N, Kejík Z, Kaplánek R, Dytrych P, Sinica A, Vozniuk O, Martásek P, Jakubek M. Preparation of Tryptanthrin Derivates Bearing a Thiosemicarbazone Moiety to Inhibit SARS-CoV-2 Replication. Separations. 2023; 10(2):73. https://doi.org/10.3390/separations10020073 (IF2.6, Q3) [Link]
Prokopová O., Blahut A., Hajduch J. et al. Influence of Isomeric Composition and Sample Handling on the Liquid Density of Hydrofluorethers Measured by Vibrating Tube Densimeter at 0.1 MPa. Int J Thermophys 44, 139 (2023). https://doi.org/10.1007/s10765-023-03247-6 (IF 2.2 Q3) [Link]
D'Acunto CW, Gbelcová H, Kaplánek R, Pospíšilová M, Havlík M, Ruml T. Chelators as Antineuroblastomas Agents. Physiol Res. 2023 Oct 27;72(S3):S277-S286. doi: 10.33549/physiolres.935184. (IF 2.1 Q3) [PubMed]
Vozniuk O, Kejík Z, Veselá K, Skaličková M, Novotný P, Hromádka R, Hajduch J, Martásek P, Jakubek M. A Fast HPLC/UV Method for Determination of Ketoprofen in Cellular Media. ChemistryOpen. 2023 Nov 13:e202300147. doi: 10.1002/open.202300147. (IF 2.3, Q3) [PubMed]
Ussia M, Urso M, Kratochvilova M, Navratil J, Balvan J, Mayorga-Martinez CC, Vyskocil J, Masarik M, Pumera M. Magnetically Driven Self-Degrading Zinc-Containing Cystine Microrobots for Treatment of Prostate Cancer. Small. 2023 Apr;19(17):e2208259. doi: 10.1002/smll.202208259. (IF 13.3, Q1) [PubMed]
Hanelova K, Raudenska M, Kratochvilova M, Navratil J, Vicar T, Bugajova M, Gumulec J, Masarik M, Balvan J. Autophagy modulators influence the content of important signalling molecules in PS-positive extracellular vesicles. Cell Commun Signal. 2023 May 24;21(1):120. doi: 10.1186/s12964-023-01126-z. (IF 8.4, Q1) [PubMed]
Raudenska M, Vicar T, Gumulec J, Masarik M. Johann Gregor Mendel: the victory of statistics over human imagination. Eur J Hum Genet. 2023 Jul;31(7):744-748. doi: 10.1038/s41431-023-01303-1.Review (IF 5.2, Q1/Q2) [PubMed]
Kejík Z, Koubková N, Krčová L, Sýkora D, Abramenko N, Veselá K, Kaplánek R, Hajduch J, Houdová Megová M, Bušek P, Šedo A, Lacina L, Smetana K Jr, Martásek P, Jakubek M. Combination of quinoxaline with pentamethinium system: Mitochondrial staining and targeting. Bioorg Chem. 2023 Sep 9;141:106816. doi: 10.1016/j.bioorg.2023.106816. (IF 5.1, Q1) [PubMed]
Kaplánek R, Kejík Z, Hajduch J, Veselá K, Kučnirová K, Skaličková M, Venhauerová A, Hosnedlová B, Hromádka R, Dytrych P, Novotný P, Abramenko N, Antonyová V, Hoskovec D, Babula P, Masařík M, Martásek P, Jakubek M. TET protein inhibitors: Potential and limitations. Biomed Pharmacother. 2023 Oct;166:115324. doi: 10.1016/j.biopha.2023.115324. (IF 7.5, Q1) [PubMed]
Raudenská M, Petrláková K, Juriňáková T, Leischner Fialová J, Fojtů M, Jakubek M, Rösel D, Brábek J, Masařík M. Engine shutdown: migrastatic strategies and prevention of metastases. Trends Cancer. 2023 Apr;9(4):293-308. doi: 10.1016/j.trecan.2023.01.001. Epub 2023 Feb 15. (IF 18.4, Q1) [PubMed]
Dytrych P, Kejík Z, Hajduch J, Kaplánek R, Veselá K, Kučnirová K, Skaličková M, Venhauerová A, Hoskovec D, Martásek P, Jakubek M. Therapeutic potential and limitations of curcumin as antimetastatic agent. Biomed Pharmacother. 2023 Jul;163:114758. doi: 10.1016/j.biopha.2023.114758. (IF 7.5, Q1) [PubMed]
Antonyová V, Kejík Z, Brogyanyi T, Kaplánek R, Veselá K, Abramenko N, Ocelka T, Masařík M, Matkowski A, Gburek J, Abel R, Goede A, Preissner R, Novotný P, Jakubek M. Non-psychotropic cannabinoids as inhibitors of TET1 protein. Bioorg Chem. 2022 Jul;124:105793. doi: 10.1016/j.bioorg.2022.105793. (IF 5.307) [PubMed] (131, I, H)
Gál P, Brábek J, Holub M, Jakubek M, Šedo A, Lacina L, Strnadová K, Dubový P, Hornychová H, Ryška A, Smetana K Jr. Autoimmunity, cancer and COVID-19 abnormally activate wound healing pathways: critical role of inflammation. Histochem Cell Biol. 2022 Jul 22:1–20. doi: 10.1007/s00418-022-02140-x. (IF 2.531) [PubMed] (131)
Talianová V, Kejík Z, Kaplánek R, Veselá K, Abramenko N, Lacina L, Strnadová K, Dvořánková B, Martásek P, Masařík M, Megová MH, Bušek P, Křížová J, Zdražilová L, Hansíková H, Vlčák E, Filimonenko V, Šedo A, Smetana K Jr, Jakubek M. New-Generation Heterocyclic Bis-Pentamethinium Salts as Potential Cytostatic Drugs with Dual IL-6R and Mitochondria-Targeting Activity. Pharmaceutics. 2022 Aug 17;14(8):1712. doi: 10.3390/pharmaceutics14081712. (IF 6.525) [PubMed] (131)
Kunachowicz D, Ściskalska M, Jakubek M, Kizek R, Kepinska M. Structural changes in selected human proteins induced by exposure to quantum dots, their biological relevance and possible biomedical applications. NanoImpact. 2022 Apr;26:100405. doi: 10.1016/j.impact.2022.100405. (IF 6.038) [PubMed] (131,I)
Hosnedlova B, Kabanov D, Kepinska M, B Narayanan VH, Parikesit AA, Fernandez C, Bjørklund G, Nguyen HV, Farid A, Sochor J, Pholosi A, Baron M, Jakubek M, Kizek R. Effect of Biosynthesized Silver Nanoparticles on Bacterial Biofilm Changes in S. aureus and E. coli. Nanomaterials (Basel). 2022 Jun 25;12(13):2183. doi: 10.3390/nano12132183. (IF 5.719) [PubMed] (131,H, I)
Fialova JL, Hönigova K, Raudenska M, Miksatkova L, Zobalova R, Navratil J, Šmigová J, Moturu TR, Vicar T, Balvan J, Vesela K, Abramenko N, Kejik Z, Kaplanek R, Gumulec J, Rosel D, Martasek P, Brábek J, Jakubek M, Neuzil J, Masarik M. Pentamethinium salts suppress key metastatic processes by regulating mitochondrial function and inhibiting dihydroorotate dehydrogenase respiration. Biomed Pharmacother. 2022 Aug 30;154:113582. doi: 10.1016/j.biopha.2022.113582. (IF 7.419) [PubMed] (131, I, H)
Hönigova K, Navratil J, Peltanova B, Polanska HH, Raudenska M, Masarik M. Metabolic tricks of cancer cells. Biochim Biophys Acta Rev Cancer. 2022 May;1877(3):188705. doi: 10.1016/j.bbcan.2022.188705. (IF 11.414) [PubMed] (131)
Peltanová B, Holcová Polanská H, Raudenská M, Balvan J, Navrátil J, Vičar T, Gumulec J, Čechová B, Kräter M, Guck J, Kalfeřt D, Grega M, Plzák J, Betka J, Masařík M. mRNA Subtype of Cancer-Associated Fibroblasts Significantly Affects Key Characteristics of Head and Neck Cancer Cells. Cancers (Basel). 2022 May 3;14(9):2286. doi: 10.3390/cancers14092286. (IF 6.575) [PubMed] (131, I, H)
Brogyányi T, Kaplánek R, Kejík Z, Hosnedlová B, Antonyová V, Abramenko N, Veselá K, Martásek P, Vokurka M, Richardson DR, Jakubek M. Azulene hydrazide-hydrazones for selective targeting of pancreatic cancer cells. Biomed Pharmacother. 2022 Nov;155:113736. doi: 10.1016/j.biopha.2022.113736. (IF 7.419) [PubMed]
Antonyová V, Tatar A, Brogyányi T, Kejík Z, Kaplánek R, Vellieux F, Abramenko N, Sinica A, Hajduch J, Novotný P, Masters BS, Martásek P, Jakubek M. Targeting of the Mitochondrial TET1 Protein by Pyrrolo[3,2-b]pyrrole Chelators. Int J Mol Sci. 2022 Sep 16;23(18):10850. doi: 10.3390/ijms231810850. (IF 6.208) [PubMed]
Peng X, Urso M, Balvan J, Masarik M, Pumera M. Self-Propelled Magnetic Dendrite-Shaped Microrobots for Photodynamic Prostate Cancer Therapy. Angew Chem Int Ed Engl. 2022 Nov 25;61(48):e202213505. doi: 10.1002/anie.202213505. (IF 16.823) [PubMed]
Raudenská M, Balvan J, Masařík M. Cell death in head and neck cancer pathogenesis and treatment. Cell Death Dis. 2021 Feb 18;12(2):192. doi: 10.1038/s41419-021-03474-5. (IF 8.469) [PubMed] (131)
Peltanova B, Liskova M, Gumulec J, Raudenska M, Polanska HH, Vaculovic T, Kalfert D, Grega M, Plzak J, Betka J, Masarik M. Sensitivity to Cisplatin in Head and Neck Cancer Cells Is Significantly Affected by Patient-Derived Cancer-Associated Fibroblasts. Int J Mol Sci. 2021 Feb 15;22(4):1912. doi: 10.3390/ijms22041912. (IF 5.924) [PubMed] (H, 131)
Fojtů M, Balvan J, Vičar T, Polanská HH, Peltanová B, Matějková S, Raudenská M, Šturala J, Mayorga-Burrezo P, Masařík M, Pumera M. Silicane Derivative Increases Doxorubicin Efficacy in an Ovarian Carcinoma Mouse Model: Fighting Drug Resistance. ACS Appl Mater Interfaces. 2021 Jul 14;13(27):31355-31370. doi: 10.1021/acsami.0c20458. (IF 9.229) [PubMed] (I,131)
Raudenska M, Balvan J, Masarik M. Crosstalk between autophagy inhibitors and endosome-related secretory pathways: a challenge for autophagy-based treatment of solid cancers. Mol Cancer. 2021 Oct 27;20(1):140. doi: 10.1186/s12943-021-01423-6. (IF 27.401) [PubMed] (131)
Münster L, Fojtů M, Muchová M, Latečka F, Káčerová S, Capáková Z, Juriňáková T, Kuřitka I, Masařík M, Vícha J. Enhancing cisplatin anticancer effectivity and migrastatic potential by modulation of molecular weight of oxidized dextran carrier. Carbohydr Polym. 2021 Nov 15;272:118461. doi: 10.1016/j.carbpol.2021.118461. (IF 9.381) [PubMed] (131)
Leischner Fialova J, Raudenska M, Jakubek M, Kejik Z, Martasek P, Babula P, Matkowski A, Filipensky P and Masarik M. Novel Mitochondria-targeted Drugs for Cancer Therapy. Mini-Reviews in Medicinal Chemistry, 2021, Vol 21, No.0. (IF 3.862) [PubMed] (B, N, H, 131)
Kejík Z, Kaplánek R, Masařík M, Babula P, Matkowski A, Filipenský P, Veselá K, Gburek J, Sýkora D, Martásek P, Jakubek M. Iron Complexes of Flavonoids-Antioxidant Capacity and Beyond. Int J Mol Sci. 2021 Jan 11;22(2):E646. doi: 10.3390/ijms22020646. (IF 5.924) [Pubmed] (N, I, H, 131)
Munster L, Fojtu M, Capakova Z, Muchova M, Musilova L, Vaculovic T, Balvan J, Kuritka I, Masarik M, Vicha J. Oxidized polysaccharides for anticancer-drug delivery: What is the role of structure? Carbohydrate Polymers 257 (2021) 117562. (IF 9.381) [Link] (131)
Abramenko N, Kejik Z, Kaplanek R, Tatar A. Brogyanyi T, Pajkova M, Sykora D, Vesela K, Antonyova V, Dytrych P, Ikeda-Saito M, Martasek P, Jakubek M. Spectroscopic study of in situ-formed metallocomplexes of proton pump inhibitors in water. Chem Biol Drug Des. 2021 Feb;97(2):305-314. doi: 10.1111/cbdd.13782. (IF 2.817) [Pubmed] (N, H, I, 131)
Shishkanova TV, Bříza T, Řezanka P, Kejík Z, Jakubek M. Pentamethinium Salts Nanocomposite for Electrochemical Detection of Heparin. Materials (Basel). 2021 Sep 17;14(18):5357. doi: 10.3390/ma14185357. (IF 3.623) [Pubmed] (131)
Abramenko N, Vellieux F, Tesařová P, Kejík Z, Kaplánek R, Lacina L, Dvořánková B, Rösel D, Brábek J, Tesař A, Jakubek M, Smetana K Jr. Estrogen Receptor Modulators in Viral Infections Such as SARS-CoV-2: Therapeutic Consequences. Int J Mol Sci. 2021 Jun 18;22(12):6551. doi: 10.3390/ijms22126551. (IF 5.923) [Pubmed] (H, 131)
Kejík Z, Kaplánek R, Dytrych P, Masařík M, Veselá K, Abramenko N, Hoskovec D, Vašáková M, Králová J, Martásek P, Jakubek M. Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design. Pharmaceutics. 2021 Nov 5;13(11):1879. doi: 10.3390/pharmaceutics13111879. (IF 6.321) [PubMed]
Jakubek M, Masařík M, Bříza T, Kaplánek R, Veselá K, Abramenko N, Martásek P. PPO-Inhibiting Herbicides and Structurally Relevant Schiff Bases: Evaluation of Inhibitory Activities against Human Protoporphyrinogen Oxidase. Processes. 2021; 9(2):383. https://doi.org/10.3390/pr9020383. (IF 2.847) [Web]
Dachev M, Bryndová J, Jakubek M, Moučka Z, Urban M. The Effects of Conjugated Linoleic Acids on Cancer. Processes. 2021; 9(3):454. https://doi.org/10.3390/pr9030454. (IF 2.847) [Web]
Antonyova V, Kejík Z, Brogyanyi T, Kaplanek R, Pajkova M, Talianova V, Hromadka R, Masarik M, Sykora D, Miksatkova L, Martasek P, Jakubek M. Role of mtDNA disturbances in the pathogenesis of Alzheimer's and Parkinson's disease. DNA Repair (Amst). 2020;91-92:102871. doi:10.1016/j.dnarep.2020.102871. (IF 3.339) [Pubmed]
Sykora D, Jindrich J, Kral V, Jakubek M, Tatar A, Kejik Z, Martasek P, Zakharov S. Formaldehyde Reacts with Amino Acids and Peptides with a Potential Role in Acute Methanol Intoxication [published online ahead of print, 2020 Apr 28]. J Anal Toxicol. 2020;bkaa039. doi:10.1093/jat/bkaa039. (IF 3.513) [Pubmed] (H, 131)
Fojtu M, Balvan J, Raudenska M, Vicar T, Sturala J, Sofer Z. Luxa J, Plutnar J, Masarik M, Pumera M. 2D Germanane Derivative as a Vector for Overcoming Doxorubicin Resistance in Cancer Cells. Applied Materials Today 20 (2020) 100697. doi: https://doi.org/10.1016/j.apmt.2020.100697. (IF 8.352) [PubMed] (131)
Raudenska M, Gumulec J, Balvan J, Masarik M. Caveolin-1 in oncogenic metabolic symbiosis [published online ahead of print, 2020 Mar 20]. Int J Cancer. 2020;10.1002/ijc.32987. doi:10.1002/ijc.32987. (IF 5,145) [Pubmed] (131)
Talianová V, Bříza T, Krčová L, Dolenský B, Králová J, Martásek P, Král V, Havlík M. Coumarin Tröger's base derivatives with cyanine substitution as selective and sensitive fluorescent lysosomal probes. Bioorg Chem. 2020 Jan;94:103447. doi: 10.1016/j.bioorg.2019.103447.(IF 4.831) [Pubmed] (B, N, 131)
Krčová L, Rimpelová S, Havlík M, Dolenský B, Vellieux F, Ruml T, Martásek P, Král V, Bříza T. Highly selective mitochondrial probes based on fluorinated pentamethinium salts: On two-photon properties and microscopic applications. Dyes and Pigments 172 (2020) 107802. https://doi.org/10.1016/j.dyepig.2019.107802. (IF 4.613) [Pdf] (B, N, 131)Feith M, Vičar T, Gumulec J, Raudenská M, Gjörloff Wingren A, Masařík M & Balvan J. (2020). Quantitative Phase Dynamics of Cancer Cell Populations Affected by Blue Light. Applied Sciences, 10(7), 2597. doi:10.3390/app10072597. (IF 2.474) [PDF]
Raudenská M, Svobodová M, Gumulec J, Falk M, Masařík M. The Importance of Cancer-Associated Fibroblasts in the Pathogenesis of Head and Neck Cancers. Význam fibroblastů asociovaných s nádorem při patogenezi karcinomů v oblasti hlavy a krku. Klin Onkol. 2020;33(1):39–48. doi:10.14735/amko202039. [PubMed]
Synytsya A, Poučková P, Zadinová M, Troshchynska Y, Štětina J, Synytsya A, Saloň I, Král V. Hydrogels based on low-methoxyl amidated citrus pectin and flaxseed gum formulated with tripeptide glycyl-l-histidyl-l-lysine improve the healing of experimental cutting wounds in rats. Int J Biol Macromol. 2020 Dec 15;165(Pt B):3156-3168. doi: 10.1016/j.ijbiomac.2020.09.251. (IF 5.162) [PubMed]
Krejcir R, Briza T, Sterba M, Simoncik O, Muller P, Coates PJ, Martasek P, Vojtesek B, Zatloukalova P. Anticancer pentamethinium salt is a potent photosensitizer inducing mitochondrial disintegration and apoptosis upon red light illumination. J Photochem Photobiol B. 2020 Aug;209:111939. doi: 10.1016/j.jphotobiol.2020.111939. (IF 4.383) [PubMed]
Mikeš P, Brož A, Sinica A, Asatiani N, Bačáková L. In vitro and in vivo testing of nanofibrous membranes doped with alaptide and L-arginine for wound treatment. Biomed Mater. 2020 Nov 26;15(6):065023. doi: 10.1088/1748-605X/ab950f. (IF 3.174) [PubMed]
Jakubek M, Kejík Z, Kaplánek R, Hromádka R, Šandriková V, Sýkora D, Antonyová V, Urban M, Dytrych P, Mikula I, Martásek P, Král V. Strategy for improved therapeutic efficiency of curcumin in the treatment of gastric cancer. Biomed Pharmacother. 2019 Aug 3;118:109278. doi: 10.1016/j.biopha.2019.109278. (IF 3.743) [PubMed] (B, N, H, 131)
Milan Jakubek, Zdeněk Kejík, Veronika Antonyová, Robert Kaplánek,
David Sýkora, Róbert Hromádka, Kateřina Vyhlídalová, Pavel Martásek & Vladimír Král (2019). Benzoisothiazole-1,1-dioxide-based synthetic receptor for zinc ion recognition in aqueous medium and its interaction with nucleic acids, Supramolecular Chemistry, 31:1, 19-27, doi:10.1080/10610278.2018.1523409. (IF 1.660) [pdf] (B, N, H, 131)
Shishkanova T, Broncova G, Němečková Z, Vrkoslav V, Král V, Matějka P. Molecular frameworks of polymerized 3‑aminobenzoic acid for chemical modification and electrochemical recognition. Journal of Electroanalytical Chemistry 832 (2019) 321-328. (IF 3.218) (N)
Hromádka R, Kejík Z, Jakubek M, Kaplánek R, Šandriková V, Urban M, Martásek P, Král V. Pigments from Filamentous Ascomycetes for Combination Therapy. Curr Med Chem. 2019;26(20):3812-3834. doi: 10.2174/0929867325666180330091933. (IF 3.249) [PubMed] (B, N, 131)
Jakubek M, Kejík Z, Kaplánek R, Antonyová V, Hromádka R, Šandriková V, Sýkora D, Martásek P, Král V. Hydrazones as novel epigenetic modulators: Correlation between TET 1 protein inhibition activity and their iron(II) binding ability. Bioorg Chem. 2019 Feb 16;88:102809. doi:10.1016/j.bioorg.2019.02.034. (IF 3.929) [PubMed] (B, N, 131)
Bříza T, Králová J, Rimpelová S, Havlík M, Kaplánek R, Kejík Z, Martásek P, Mikula I, Džubák P, Hajdúch M, Ruml T, Král V. Pentamethinium salts as ligands for cancer: Sulfated polysaccharide co-receptors as possible therapeutic target. Bioorg Chem. 2019 Feb;82:74-85. doi: 10.1016/j.bioorg.2018.02.011.(IF 3.929) [PubMed] (B, N)
Havlík M, Talianová V, Kaplánek R, Bříza T, Dolenský B, Králová J, Martásek P, Král V. Versatile fluorophores for bioimaging applications: π-expanded naphthalimide derivatives with skeletal and appendage diversity. Chem Commun (Camb). 2019 Feb 26;55(18):2696-2699. doi: 10.1039/c8cc09638d. (IF 6.290) [PubMed] (B, N, 131)
Shishkanova T, Broncova G, Filt P, Král V, Barek J. Voltammetric Detection of Catecholamine Metabolites Using Troger's Base Modified Electrode. Electroanalysis. 2018, 30(4), 734-739. ISSN 1040-0397. doi: 10.1002/elan.201700635. (IF 2.851) [Web] (N, 131)
Broncová G, Matějka P, Němečková Z, Vrkoslav V, Shishkanova T. Electrochemical Detection of Sialic Acid Using Phenylboronic Acid-modified Poly(Diaminobenzoic Acid) Electrodes. Electroanalysis. 2018, 30(4), 672-680. ISSN 1040-0397. doi: 10.1002/elan.201700634. (IF 2.851) [Web] (N, 131)
Brezániová I, Záruba K, Králová J, Sinica A, Adámková H, Ulbrich P, Poučková P, Hrubý M, Štěpánek P, Král V. Silica-based nanoparticles are efficient delivery systems for temoporfin. Photodiagnosis Photodyn Ther. 2018 Mar;21:275-284. doi: 10.1016/j.pdpdt.2017.12.014. Epub 2017 Dec 27. (IF 2.895) [PubMed] (B, N, 131)
D'Acunto CW, Kaplánek R, Gbelcová H, Kejík Z, Bříza T, Vasina L, Havlík M, Ruml T, Král V. Metallomics for Alzheimer's disease treatment: Use of new generation of chelators combining metal-cation binding and transport properties. Eur J Med Chem. 2018 Apr 25;150:140-155. doi: 10.1016/j.ejmech.2018.02.084. (IF 4.519) [PubMed] (B, N, I)
Jakubek M, Kejík Z, Kaplánek R, Veselá H, Sýkora D, Martásek P, Král V. Perimidine-based synthetic receptors for determination of copper(II) in water solution. Supramolecular Chemistry 2018, Vol. 30, No.3, 218-226. https://doi.org/10.1080/10610278.2017.1414216. (IF 1.451) [PDF] (B, N, 131)
Kejík Z, Jakubek M, Kaplánek R, Králová J, Mikula I, Martásek P, Král V. Epigenetic agents in combined anticancer therapy. Future Med Chem. 2018 Apr 20.doi: 10.4155/fmc-2017-0203. (IF 3.969) [PubMed] (B, N, 131)
Optical probes and sensors as perspective tools in epigenetics. Kejík Z, Kaplanek R, Havlik M, Briza T, Jakubek M, Kralova J, Mikula I, Martasek P, Kral V. Bioorg Med Chem. 2017 Apr 15;25(8):2295-2306. doi: 10.1016/j.bmc.2017.01.011. (IF 2.930) [PDF] (B, N)
Methinium colorimetric sensors for the determination of cholesterol sulfate in an aqueous medium. Kejik Z, Havlik M, Briza T, Kaplanek R, Dolensky B, Kralova J, Martasek P, Kral V., Sensor Actuat B-Chem 245 (2017) 1032-1038. doi: 10.1016/j.snb.2017.01.185. [Epub ahead of print]
(IF 5.401) [PDF] (B, N, 131)
Self-assembled chitosan-alginate polyplex nanoparticles containing temoporfin. Ingrid Brezaninova, Jiri Trousil, Zulfiya Cernochova, Vladimir Kral, Martin Hruby, Petr Stepanek, Miroslav Slouf. Colloid Polym Sci. Published online 07 January 2017. (IF: 1.723) [PDF] (B, N, 131)
Water soluble chromone Schiff base derivatives as fluorescence receptor for aluminium(III). Jakubek, M.; Kejik, Z.; Parchansky, V.; Kaplanek, R.; Vasina, L.; Martasek, P.; Kral, V., Supramol. Chem. 2017, Vol. 29, No. 1, 1-7. DOI: 10.1080/10610278.2016.1153095. (IF 1.264) [placený přístup] (B, N, 131)
Amino-substituted Tröger’s base: electrochemical polymerization and characterization of the polymer film. Tatiana V Shishkanova, Martin Havlík, Vladimír Král, Dušan Kopecký, Pavel Matějka, Marcela Dendisová, Vladimír M. Mirsky. Electrochimica Acta 224 (2017) 439-445. DOI:http://dx.doi.org/10.1016/j.electa.2016.12.061. (IF 4.798) [PDF] (B, N, I, 131)
Aluminium(III) sensing by pyridoxal hydrazone utilising the chelation enhanced fluorescence effect. Kejík, Z.; Kaplánek, R.; Havlík, M.; Bříza, T.; Vavřinová, D.; Dolenský, B.; Martásek, P.; Král, V., J. Lumin. 2016, 180, 269-277. DOI: 10.1016/j.jlumin.2016.08.047 (IF: 2.693 ) [PDF] (B, N, 131)
Multifunctional Bile Acid Derivatives as Efficient RNA Transporters (Carriers). Liudmila Vasina, Bhupendra C Reddy, Elina Sievänen, Erkki Kolehmainen and Vladimir Král, dx.doi.org/10.4172/2325-9604.1000147. (IF 0.7) [PDF] (B, N, I, 131)
Specific ligands based on Troger’s base derivatives for the recognition of glycosaminoglycans. Zdenek Kejík, Tomas Bríza Martin Havlík, Bohumil Dolenský, Robert Kaplanek, Jarmila Kralova , Ivan Mikula, Pavel Martasek , Vladimír Kral; dx.doi.org/10.1016/j.dyepig.2016.07.002. (IF 4.055) [PDF] (B, N, 131)
Large scale preparation of up- converting YF3:YbEr nanocrystals with various sizes by solvothermal syntheses using ionic liquid bmimCl. Bartunek, V.; Rak, J.; Pelankova, B.; Junkova, J.; Mezlikova, M.; Kral, V.; Kuchar, M.; Engstova, H.; Jezek, P.; Smucler, R., J. Fluorine Chem. 2016, 188, 14-17. DOI: 10.1016/j.jfluchem.2016.05.015 (IF: 1.952) [PDF] (B, N, I, H)
Supramolecular nanosized siRNA-carrier complexes for efficient into-cell transport, Vasina, L.; Kral, V., Наука в современном мире 2016, 5, 47-50. (není IF) [PDF] (B,N)